Skip to content

Study of Patients Hospitalized in Specialized Cognitive-behavioral Unit (UCC)

Patient Outcomes After an Hospitalization in the Specialized Cognitive-behavioral Unit (UCC) of Toulon

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03485898
Acronym
UCC
Enrollment
58
Registered
2018-04-03
Start date
2018-04-12
Completion date
2019-07-31
Last updated
2019-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behavior Disorders

Keywords

UCC, mortality, alzheimer's disease, longitudinal study

Brief summary

The purpose of the study is to assess the mortality of patient discharged from the specialized cognitive-behavioral unit (UCC) of Toulon.

Detailed description

The purpose of specialized cognitive-behavioral unit is to take care of patients demented, valid and with disruptive behavior disorders. The hypothesis is that analyzing the healthcare of these discharged patients might provide a view of the benefices of these units. The study will be explained to the eligible subjects if they are able to understand it, or to their trusted person, primary caregiver or legal representative. Medical information will be collected during and after the hospitalization in the specialized cognitive-behavioral unit. The investigator will call the medical staff and the primary caregiver at 3, 6, and 12 months after the patient's discharge, in order to collect study data.

Interventions

None listed

Sponsors

Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Inpatient at the UCC of Toulon

Exclusion criteria

* Patient already included in the study ( a patient cannot be included twice during the study) * Non-affiliated to a social security regimen * Objection of the patient, the trusted person, the legal representative, the relative or the member of the family (depending on the overall condition of the patient)

Design outcomes

Primary

MeasureTime frameDescription
Mortality rate at 12 month after patient's discharge from UCC12 monthsNumber of dead patient at 12 month on the total number of patient included

Secondary

MeasureTime frameDescription
Assess the primary mortality risk factors regarding all the collected data.12 monthscorrelation analysis of collected data and survival data will lead to prediction of survival model with the most relevant survival variable
Create a predictive score for 6 and 12 month mortality6 and 12 monthsall the survival variable will have a score according to the survival prediction model - this endpoint is adressed in order to create a predictive scale/score.
Mortality rate during the hospitalization in the UCC12 monthsNumber of all dead patient on the total number of patient included
Mortality rate at 3 and 6 month after patient's discharge from UCC3 and 6 monthsNumber of dead patient at 3 and 6 month on the total number of patient included
Analysis of the number of treatment taken during the study12 monthsDescriptive analysis
Analysis of the different classes of treatment taken during the study12 monthsDescriptive analysis of the rate of different classes of treatment taken by patient during the study
Analysis of the treatment's mode of delivery12 monthsDescriptive analysis
Analysis of hospitalisation rate12 monthsDescriptive analysis

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026